Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases
This paper deals with the question of how to price drugs for tropical diseases. The thesis defended in the paper is: (i) there should be no legal constraints on the profits pharmaceutical companies can make on their products for tropical diseases. In essence, (i) expresses the idea that drugs for tr...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
BMJ Publ.
2009
|
| In: |
Journal of medical ethics
Year: 2009, Volume: 35, Issue: 5, Pages: 315-319 |
| Online Access: |
Volltext (JSTOR) Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1816137162 | ||
| 003 | DE-627 | ||
| 005 | 20230427161243.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220908s2009 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/jme.2008.026369 |2 doi | |
| 035 | |a (DE-627)1816137162 | ||
| 035 | |a (DE-599)KXP1816137162 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Sonderholm, J. |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a This paper deals with the question of how to price drugs for tropical diseases. The thesis defended in the paper is: (i) there should be no legal constraints on the profits pharmaceutical companies can make on their products for tropical diseases. In essence, (i) expresses the idea that drugs for tropical diseases should be treated as any other product on the free market and that the producers of these drugs should be allowed to sell their products at whatever price the market can bear. The main argument in favour of (i) is first outlined. Five common arguments against (i) are thereafter discussed, and it is argued that all of these fail in their intended purpose. | ||
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical ethics |d London : BMJ Publ., 1975 |g 35(2009), 5, Seite 315-319 |h Online-Ressource |w (DE-627)323607802 |w (DE-600)2026397-1 |w (DE-576)260773972 |x 1473-4257 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2009 |g number:5 |g pages:315-319 |
| 856 | |3 Volltext |u http://www.jstor.org/stable/27720327 |x JSTOR | ||
| 856 | 4 | 0 | |u https://doi.org/10.1136/jme.2008.026369 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://jme.bmj.com/content/35/5/315.abstract |x Verlag |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 35 |j 2009 |e 5 |h 315-319 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4185591047 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1816137162 | ||
| LOK | |0 005 20220908053508 | ||
| LOK | |0 008 220908||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2022-08-02#A06C5750218E2FBDAE2162219AA82F3CEC673EE1 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 866 |x JSTOR#http://www.jstor.org/stable/27720327 | ||
| LOK | |0 935 |a ixzs |a ixrk |a zota | ||
| OAS | |a 1 |b inherited from superior work | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||